glp 1 agonist long term side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists long term side effects of
Description
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
SestiGAvogaroABelcastroSBonoraBMCrociMDanieleGet al
Back Habener, JF (Oct 1981) 'Recent advances in parathyroid hormone research', Clinical Biochemistry , 14/5, 223-29
Risk of esophageal and gastric cancer in patients with type 2 diabetes receiving glucagon-like peptide-1 receptor agonists (GLP-1 RAs): a national analysis
Potential Cost-Saving Strategies Research suggests potential strategies for managing costs while maintaining therapeutic benefits
